Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas
Authors:
- Charlotte NazonCNCharlotte Nazon
- Marina PierrevelcinMPMarina Pierrevelcin
- Thibault WillaumeTWThibault Willaume
- Benoît LhermitteBLBenoît Lhermitte
- Noelle WeingertnerNWNoelle Weingertner
- Antonio Di MarcoAMAntonio Di Marco
- Laurent BundLBLaurent Bund
- Florence VincentFVFlorence Vincent
- Guillaume BierryGBGuillaume Bierry
- Anne Gomez-BrouchetAGAnne Gomez-Brouchet
- Françoise RediniFRFrançoise Redini
- Nathalie GasparNGNathalie Gaspar
Open Access
Abstract
Background: Osteosarcomas (OTS) represent the most common primary bone cancer diagnosed in adolescents and young adults. Despite remarkable advances, there are no objective molecular or imaging markers able to predict an OTS outcome at diagnosis. Focusing on biomarkers contributing broadly to treatment resistance, we examine the interplay between the tumor-associated macrophages and intra-tumor hypoxia. Methods: Radiological and immunohistochemical (IHC) data were correlated with the outcome in a retrospective and monocentric cohort of 30 pediatric OTS. We studied hypoxic (pS6, phospho-mTor, HIF-1α and carbonic anhydrase IX (CAIX)) and macrophagic (CD68 and CD163) biomarkers. Results: The imaging analyses were based on MRI manual volumetric measures on axial post-contrast T1 weighted images, where, for each tumor, we determined the necrotic volume and its ratio to the entire tumor volume. When they were above 50 cm3 and 20%, respectively, they correlated with a worse overall survival (p = 0.0072 and p = 0.0136, respectively) and event-free survival (p = 0.0059 and p = 0.0143, respectively). IHC assessments enable a significant statistical link between HIF-1α/CAIX hyper-expressions, CD68+ cells and a worse outcome, whereas activation of mTor pathway was linked to a better survival rate and CD163+ cells. Conclusions: This study evidenced the links between hypoxia and immunity in OTS, as their poor outcome may be related to a larger necrotic volume on diagnostic MRI and, in biopsies, to a specific IHC profile.Keywords
Funding Information
- LifePink and Mimi pour la vie associations (NA)
This publication has 53 references indexed in Scilit:
- Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma CellsFrontiers in Oncology, 2013
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Tumour macrophages as potential targets of bisphosphonatesJournal of Translational Medicine, 2011
- Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Hypoxia Markers in Human Osteosarcoma: An Exploratory StudyClinical Orthopaedics and Related Research, 2008
- Hypoxia and cancerJournal of Molecular Medicine, 2007
- SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsEuropean Journal of Cancer, 2007
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000